1.
Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on Global Embolotherapy Market
4. Executive Summary
5.
Voice of Customer
6.
Global Embolotherapy Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Indication (Cancer, Gastrointestinal Disorders, Neurological
Diseases, Peripheral Vascular Disease, Urological & Nephrological Disorders)
6.2.2. By Product (Embolic
Agents (Embolic Coils, Embolic Plug Systems, Liquid Embolic Agents,
Microspheres, Detachable Balloons), Support Devices (Microcatheters, Guidewires))
6.2.3. By Type (Chemoembolization, Radioembolization, Arterial embolization,
Combination)
6.2.4. By End-User (Hospitals,
Clinics, Ambulatory Surgical Centers, Others)
6.2.5. By Company (2020)
6.2.6. By Region
6.3. Product Market Map
7.
Asia-Pacific Embolotherapy Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Indication
7.2.2. By Embolic agents
7.2.3. By Types
7.2.4. By End-User
7.2.5. By Country
7.3.
Asia-Pacific: Country Analysis
7.3.1. China Embolotherapy
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Indication
7.3.1.2.2.
By Embolic agents
7.3.1.2.3.
By Types
7.3.1.2.4.
By End-User
7.3.2. India Embolotherapy
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Indication
7.3.2.2.2.
By Embolic agents
7.3.2.2.3.
By Types
7.3.2.2.4.
By End-User
7.3.3. Japan Embolotherapy
Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Indication
7.3.3.2.2.
By Embolic agents
7.3.3.2.3.
By Types
7.3.3.2.4.
By End-User
7.3.4. South Korea Embolotherapy
Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Indication
7.3.4.2.2.
By Embolic agents
7.3.4.2.3.
By Types
7.3.4.2.4.
By End-User
7.3.5. Singapore
Embolotherapy Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Indication
7.3.5.2.2.
By Embolic agents
7.3.5.2.3.
By Types
7.3.5.2.4.
By End-User
7.3.6. Australia
Embolotherapy Market Outlook
7.3.6.1.
Market Size & Forecast
7.3.6.1.1.
By Value
7.3.6.2.
Market Share & Forecast
7.3.6.2.1.
By Indication
7.3.6.2.2.
By Embolic agents
7.3.6.2.3.
By Types
7.3.6.2.4.
By End-User
8.
Europe Embolotherapy Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Indication
8.2.2. By Embolic agents
8.2.3. By Types
8.2.4. By End-User
8.2.5. By Country
8.3.
Europe: Country Analysis
8.3.1. France Embolotherapy
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Indication
8.3.1.2.2.
By Embolic agents
8.3.1.2.3.
By Types
8.3.1.2.4.
By End-User
8.3.2. Germany
Embolotherapy Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Indication
8.3.2.2.2.
By Embolic agents
8.3.2.2.3.
By Types
8.3.2.2.4.
By End-User
8.3.3. United Kingdom
Embolotherapy Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Indication
8.3.3.2.2.
By Embolic agents
8.3.3.2.3.
By Types
8.3.3.2.4.
By End-User
8.3.4. Italy Embolotherapy
Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Indication
8.3.4.2.2.
By Embolic agents
8.3.4.2.3.
By Types
8.3.4.2.4.
By End-User
8.3.5. Russia Embolotherapy
Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Indication
8.3.5.2.2.
By Embolic agents
8.3.5.2.3.
By Types
8.3.5.2.4.
By End-User
8.3.6. Spain Embolotherapy
Market Outlook
8.3.6.1.
Market Size & Forecast
8.3.6.1.1.
By Value
8.3.6.2.
Market Share & Forecast
8.3.6.2.1.
By Indication
8.3.6.2.2.
By Embolic agents
8.3.6.2.3.
By Types
8.3.6.2.4.
By End-User
9.
North America Embolotherapy Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Indication
9.2.2. By Embolic agents
9.2.3. By Types
9.2.4. By End-User
9.2.5. By Country
9.3.
North America: Country Analysis
9.3.1. United States Embolotherapy
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Indication
9.3.1.2.2.
By Embolic agents
9.3.1.2.3.
By Types
9.3.1.2.4.
By End-User
9.3.2. Mexico Embolotherapy
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Indication
9.3.2.2.2.
By Embolic agents
9.3.2.2.3.
By Types
9.3.2.2.4.
By End-User
9.3.3. Canada Embolotherapy
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Indication
9.3.3.2.2.
By Embolic agents
9.3.3.2.3.
By Types
9.3.3.2.4.
By End-User
10.
South America Embolotherapy Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Indication
10.2.2. By Embolic agents
10.2.3. By Types
10.2.4. By End-User
10.2.5. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Embolotherapy
Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Indication
10.3.1.2.2.
By Embolic agents
10.3.1.2.3.
By Types
10.3.1.2.4.
By End-User
10.3.2. Argentina Embolotherapy
Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Indication
10.3.2.2.2.
By Embolic agents
10.3.2.2.3.
By Types
10.3.2.2.4.
By End-User
10.3.3. Colombia
Embolotherapy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Indication
10.3.3.2.2.
By Embolic agents
10.3.3.2.3.
By Types
10.3.3.2.4.
By End-User
11.
Middle East and Africa Embolotherapy Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Indication
11.2.2. By Embolic agents
11.2.3. By Types
11.2.4. By End-User
11.2.5. By Country
11.3.
MEA: Country Analysis
11.3.1. South Africa
Embolotherapy Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Indication
11.3.1.2.2.
By Embolic agents
11.3.1.2.3.
By Types
11.3.1.2.4.
By End-User
11.3.2. Saudi Arabia Embolotherapy
Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Indication
11.3.2.2.2.
By Embolic agents
11.3.2.2.3.
By Types
11.3.2.2.4.
By End-User
11.3.3. UAE Embolotherapy
Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Indication
11.3.3.2.2.
By Embolic agents
11.3.3.2.3.
By Types
11.3.3.2.4.
By End-User
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends & Developments
14.
Competitive Landscape
14.1.
Competition Outlook
14.2.
Players Profiled (Leading Companies)
14.2.1. Boston Scientific Corporation
14.2.2. Terumo Corporation
14.2.3. Medtronic Plc.
14.2.4. Johnson & Johnson
14.2.5. Stryker Corporation
14.2.6. Kaneka Corporation
14.2.7. Abbott Laboratories, Inc.
14.2.8. Sirtex Medical Limited
14.2.9. Acandis GmbH
14.2.10.
Cook Medical Inc
14.2.11.
Penumbra, Inc.
14.2.12.
Merit Medical Systems, Inc.
14.2.13.
Meril Life Sciences Pvt. Ltd.
14.2.14.
Cardiva Medical Inc (Haemonetics Corporation)
14.2.15.
Shape Memory Medical Inc.
14.2.16.
Artio Medical Inc.
14.2.17.
Rapid Medical Ltd.
14.2.18.
Emboline, Inc.
14.2.19.
IMbiotechnologies Ltd.
14.2.20.
Balt Extrusion SAS
15. Strategic Recommendations
16. About Us & Disclaimer
(Note:
The companies list can be customized based on the client requirements.)
In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com